FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Ulrike Leiter

Research Profile

Disorders

Geographic Areas

Germany

Concepts & Ideas

Procedures

Chemicals & Drugs

S100 Proteins

Anatomy

Lymph Nodes

Co-author Network

Publications

TOP 3
Laura Held; Ulrike Leiter; Jane L Messina; Gisela Metzler; Thomas K Eigentler; Claus Garbe; L Frank Glass; Jürgen Bauer
Proliferative activity, chromosomal aberrations, and tumor-specific mutations in the differential diagnosis between blue nevi and melanoma.
Benjamin Weide; Ulrike Leiter; Friedegund Meier; Annette Pflugfelder; Jürgen Bauer; Petra Büttner; Thomas K Eigentler; Christine Faller; Andrea Forschner; Claus Garbe
Prognostic factors of melanoma patients with satellite or in-transit metastasis at the time of stage III diagnosis.
Laura Held; Ulrike Leiter; Thomas K Eigentler; Claus Garbe; Mark-Jürgen Berneburg
Effective combination of photodynamic therapy and imiquimod 5% cream in the treatment of actinic keratoses: three cases.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Ulrike Leiter (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Laura Held; Ulrike Leiter; Jane L Messina; Gisela Metzler; Thomas K Eigentler; Claus Garbe; L Frank Glass; Jürgen Bauer
Proliferative activity, chromosomal aberrations, and tumor-specific mutations in the differential diagnosis between blue nevi and melanoma.
The American journal of pathology 2013;182(3):640-5.
2013: Benjamin Weide; Ulrike Leiter; Friedegund Meier; Annette Pflugfelder; Jürgen Bauer; Petra Büttner; Thomas K Eigentler; Christine Faller; Andrea Forschner; Claus Garbe
Prognostic factors of melanoma patients with satellite or in-transit metastasis at the time of stage III diagnosis.
PloS one 2013;8(4):e63137.
2013: Laura Held; Ulrike Leiter; Thomas K Eigentler; Claus Garbe; Mark-Jürgen Berneburg
Effective combination of photodynamic therapy and imiquimod 5% cream in the treatment of actinic keratoses: three cases.
BioMed research international 2013;2013():102698.
2012: Laura Held; Ulrike Leiter; Jane Messina; Gisela Metzler; Juergen Bauer; Thomas K Eigentler; Jeannette Gogel; Claus Garbe
Recurrent nodules in a periauricular plaque-type blue nevus with fatal outcome.
Journal of cutaneous pathology 2012;39(12):1088-93.
2012: Benjamin Weide; M Witte; Ulrike Leiter; F Meier; A Pflugfelder; J Bauer; P Büttner; Thomas K Eigentler; M Elsässer; C Garbe
Serum markers lactate dehydrogenase and S100B predict independently disease outcome in melanoma patients with distant metastasis.
British journal of cancer 2012;107(3):422-8.
2012: Otmar Elsaesser; Helmut Breuninger; Petra G Buettner; Thomas K Eigentler; Ulrike Leiter; Friedegund Meier; Gisela Metzler; Benjamin Weide; Claus Garbe
Prognosis of sentinel node staged patients with primary cutaneous melanoma.
PloS one 2012;7(1):e29791.
2011: Alexandra Boehringer; Claus Garbe; Ulrike Leiter; Gisela Metzler; Matthias Moehrle; Helmut Breuninger
Extramammary Paget's disease: extended subclinical growth detected using three-dimensional histology in routine paraffin procedure and course of the disease.
Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] 2011;37(10):1417-26.
2011: Liljana Mervic; Ulrike Leiter; Friedegund Meier; Thomas K Eigentler; Andrea Forschner; Gisela Metzler; Igor Bartenjev; Petra Büttner; Claus Garbe
Sex differences in survival of cutaneous melanoma are age dependent: an analysis of 7338 patients.
Melanoma research 2011;21(3):244-52.
2011: Anne F Pfeil; Ulrike Leiter; Petra G Buettner; Thomas K Eigentler; Benjamin Weide; Friedegund Meier; Claus Garbe
Melanoma of unknown primary is correctly classified by the AJCC melanoma classification from 2009.
Melanoma research 2011;21(3):228-34.
2011: Benjamin Weide; Thomas K Eigentler; Annette Pflugfelder; Ulrike Leiter; Friedegund Meier; Jürgen Bauer; Diethard Schmidt; Peter Radny; Claudia Pföhler; Claus Garbe
Survival after intratumoral interleukin-2 treatment of 72 melanoma patients and response upon the first chemotherapy during follow-up.
Cancer immunology, immunotherapy : CII 2011;60(4):487-93.
2011: Annette Pflugfelder; Thomas K Eigentler; Ulrike Keim; Benjamin Weide; Ulrike Leiter; Kristian Ikenberg; Mark Berneburg; Claus Garbe
Effectiveness of carboplatin and paclitaxel as first- and second-line treatment in 61 patients with metastatic melanoma.
PloS one 2011;6(2):e16882.
2010: Ulrike Leiter; Petra G Buettner; Thomas K Eigentler; Andrea Forschner; Friedegund Meier; Claus Garbe
Is detection of melanoma metastasis during surveillance in an early phase of development associated with a survival benefit?
Melanoma research 2010;20(3):240-6.
2010: Annette Pflugfelder; Benjamin Weide; Thomas K Eigentler; Andrea Forschner; Ulrike Leiter; Laura Held; Friedegund Meier; Claus Garbe
Incisional biopsy and melanoma prognosis: Facts and controversies.
Clinics in dermatology 2010;28(3):316-8.
2010: Ulrike Leiter; Thomas K Eigentler; Andrea Forschner; Annette Pflugfelder; Benjamin Weide; Laura Held; Friedegund Meier; Claus Garbe
Excision guidelines and follow-up strategies in cutaneous melanoma: Facts and controversies.
Clinics in dermatology 2010;28(3):311-5.
2010: Andrea Forschner; Thomas K Eigentler; Annette Pflugfelder; Ulrike Leiter; Benjamin Weide; Laura Held; Friedegund Meier; Claus Garbe
Melanoma staging: facts and controversies.
Clinics in dermatology 2010;28(3):275-80.
2010: M Staudt; Konstantinos G Lasithiotakis; Ulrike Leiter; Friedegund Meier; Thomas K Eigentler; D D; Marcos Tatagiba; Peter Brossart; Claus Garbe
Determinants of survival in patients with brain metastases from cutaneous melanoma.
British journal of cancer 2010;102(8):1213-8.
2010: Ulrike Leiter; Claus Garbe
[Skin cancer in organ transplant patients. Epidemiology and management].
Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete 2010;61(3):207-13.
2010: Ulrike Leiter; Petra G Buettner; Katrin Bohnenberger; Thomas K Eigentler; Friedegund Meier; Matthias Moehrle; Helmut Breuninger; Claus Garbe
Sentinel lymph node dissection in primary melanoma reduces subsequent regional lymph node metastasis as well as distant metastasis after nodal involvement.
Annals of surgical oncology 2010;17(1):129-37.
2009: Friedegund Meier; emmanuella guenova; Stephan Clasen; Thomas K Eigentler; Andrea Forschner; Ulrike Leiter; Christina Zielinski; Björn Knaudt; Claus Garbe; Mark Berneburg
Significant response after treatment with the mTOR inhibitor sirolimus in combination with carboplatin and paclitaxel in metastatic melanoma patients.
Journal of the American Academy of Dermatology 2009;60(5):863-8.
2008: Konstantinos G Lasithiotakis; Ulrike Leiter; Friedegund Meier; Thomas K Eigentler; Gisela Metzler; Matthias Moehrle; Helmut Breuninger; Claus Garbe
Age and gender are significant independent predictors of survival in primary cutaneous melanoma.
Cancer 2008;112(8):1795-804.
2008: Silke S Schwager; Ulrike Leiter; Petra G Buettner; Christiane Voit; Wolfgang Marsch; Ralf Gutzmer; Helmut Näher; Harald Gollnick; Eva Bettina Bröcker; Claus Garbe
Management of primary and metastasized melanoma in Germany in the time period 1976-2005: an analysis of the Central Malignant Melanoma Registry of the German Dermatological Society.
Melanoma research 2008;18(2):112-9.
2008: Ulrike Leiter; Claus Garbe
Epidemiology of melanoma and nonmelanoma skin cancer--the role of sunlight.
Advances in experimental medicine and biology 2008;624():89-103.
2007: Konstantinos G Lasithiotakis; Ulrike Leiter; Thomas K Eigentler; Helmut Breuninger; Gisela Metzler; Friedegund Meier; Claus Garbe
Improvement of overall survival of patients with cutaneous melanoma in Germany, 1976-2001: which factors contributed?
Cancer 2007;109(6):1174-82.
2006: B Hoersch; Ulrike Leiter; Claus Garbe
Is head and neck melanoma a distinct entity? A clinical registry-based comparative study in 5702 patients with melanoma.
The British journal of dermatology 2006;155(4):771-7.
2006: Konstantinos G Lasithiotakis; Ulrike Leiter; Roman Gorkievicz; Thomas K Eigentler; Helmut Breuninger; Gisela Metzler; Waltraud Strobel; Claus Garbe
The incidence and mortality of cutaneous melanoma in Southern Germany: trends by anatomic site and pathologic characteristics, 1976 to 2003.
Cancer 2006;107(6):1331-9.
2005: Petra G Buettner; Ulrike Leiter; Thomas K Eigentler; Claus Garbe
Development of prognostic factors and survival in cutaneous melanoma over 25 years: An analysis of the Central Malignant Melanoma Registry of the German Dermatological Society.
Cancer 2005;103(3):616-24.
2004: Thomas K Eigentler; Petra G Buettner; Ulrike Leiter; Claus Garbe
Impact of ulceration in stages I to III cutaneous melanoma as staged by the American Joint Committee on Cancer Staging System: an analysis of the German Central Malignant Melanoma Registry.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(21):4376-83.
2004: Ulrike Leiter; Petra G Buettner; Thomas K Eigentler; Claus Garbe
Prognostic factors of thin cutaneous melanoma: an analysis of the central malignant melanoma registry of the german dermatological society.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(18):3660-7.
2004: Ulrike Leiter; Friedegund Meier; Birgit Schittek; Claus Garbe
The natural course of cutaneous melanoma.
Journal of surgical oncology 2004;86(4):172-8.
2003: Claus Garbe; Ulrike Leiter; Ulf Ellwanger; Hans-Juergen Blaheta; Friedegund Meier; Gernot Rassner; Birgit Schittek
Diagnostic value and prognostic significance of protein S-100beta, melanoma-inhibitory activity, and tyrosinase/MART-1 reverse transcription-polymerase chain reaction in the follow-up of high-risk melanoma patients.
Cancer 2003;97(7):1737-45.